Tacrolimus Capsule
Product Images NDC 55154-4168

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 55154-4168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-tacrolimus (D4a7fb82 5ff6 4ffc Bec5 Ff0d50347a9b 01)

Structure-tacrolimus (D4a7fb82 5ff6 4ffc Bec5 Ff0d50347a9b 01)
Chemical structure of tacrolimus. The diagram illustrates the molecular layout including various rings, hydroxyl groups, and other functional groups characteristic of tacrolimus hydrate.*
FDA Label Image

1mg Bag Label (6aa116fa C815 4e95 8808 F1dcbf3792e4 00)

1mg Bag Label (6aa116fa C815 4e95 8808 F1dcbf3792e4 00)
Tacrolimus capsules, USP 1 mg oral dosage form. The package contains 10 capsules and is labeled for institutional use only, not child resistant. It includes storage instructions and a warning to dispense with patient information leaflet. The label lists Cardinal Health 107, LLC as distributor and Major Pharmaceuticals as packager.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.